[1]
“Machine Learning-Driven Comparative Effectiveness Research: Utilizing Random Forest and XGBoost to Predict Patient Response and Adverse Drug Reactions to First-Line Antidiabetic Therapies”, TSP, vol. 2, no. 2, Jun. 2026, Accessed: Jun. 28, 2026. [Online]. Available: https://www.thesciencepostjournal.com/index.php/tsp/article/view/155